Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Abercrombie & Fitch Co. (ANF): Did Aeropostale, Inc. (ARO) Stock Find Its Bottom?

Teen-oriented retailer Aeropostale, Inc. (NYSE:ARO) briefly touched its 52-week low at the end of last month when it delivered less-than-stellar results for the previous quarter. The company was facing one of the most difficult retail environments in recent memory, along with unfavorable weather conditions, poor store traffic, high promotional expenses, and an all-around forgettable few months. Top-line sales fell from the year-ago level, and the company posted a much wider loss- — $0.34 per share — than last year’s $0.16 per-share loss. The question now is one that’s facing many retailers and their investors: Is the stock at an inflection point and ready for bargain hunters, or is Aeropostale about to fall off the hanger?

Aeropostale, Inc. (NYSE:ARO)


Not entirely due to internal issues, Aeropostale, Inc. (NYSE:ARO)’s earnings simply stunk this past quarter. Top-line sales dropped 6%, to $454 million, which was actually only marginally lower than analyst estimates. But high promotional fees squeezed margins, and the bottom-line profit came in, as mentioned, at an adjusted loss of $0.34 per share.

Other financial figures looked equally poor. Same-store sales crumbled 15% over the prior year’s quarter, even when including the e-commerce sales — a relative bright spot for the company. Net revenue for that segment grew by 22%, to $39 million, or roughly 9% of the company’s total sales.

Looking ahead, management is expecting a third quarter net income loss in the range of $0.21 to $0.26 per share. Aeropostale, Inc. (NYSE:ARO) has also decided to increase its store closures to 30-40 over the fiscal year, up from 15-20.

So, the past quarter, and the coming quarter, both leave little to love about the company, and the full year probably won’t end up much better. But what about beyond fiscal 2013 — will cost cutting and better merchandising make today’s stock price a bargain?

Compelling factors

One thing investors should note about Aeropostale, Inc. (NYSE:ARO), regardless of its poor performance, is its balance sheet strength. With a little more than $100 million in cash, and zero debt on the books, and a (hopefully) more efficient, streamlined business on the horizon, Aeropostale stock is certainly priced to sell. The company has an enterprise value of roughly $540 million, and last year generated $72.5 million in free cash flow.

Abercrombie & Fitch Co. (NYSE:ANF) is cheaper on a trailing EV/EBITDA basis, and while the company holds a little more than $200 million in debt, it, too, appears to be nearing a bottom for its business, and management is cutting costs and store count to compensate for poor sales.

For deep turnaround plays, both Aeropostale, Inc. (NYSE:ARO) and Abercrombie & Fitch Co. (NYSE:ANF) are worthy of a closer look. Most of Wall Street has labeled both stocks relatively untouchable, which is a good sign of better things to come. Still, these are riskier plays that only more experienced deep-value investors with retail experience should consider.

The article Did Aeropostale Stock Find Its Bottom? originally appeared on and is written by Michael Lewis.

Fool contributor Michael Lewis has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!